Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Combination therapy with injectable platelet-rich fibrin and microneedling for male androgenetic alopecia: an evaluation of current practice

Combination therapy with injectable platelet-rich fibrin and microneedling for male androgenetic... Introduction:Within the past 20 years, significant advances have taken place within the realm of aesthetic medicine to manage hair loss. Several human blood preparations have been found to contain regenerative properties suitable for hair rejuvenation and, subsequently, have emerged onto the market. An advanced and liquid version of platelet-rich fibrin, injectable platelet-rich fibrin (iPRF) is one such product. This article evaluates the combination of iPRF with microneedling (MN) for the treatment of male androgenetic alopecia (AGA) compared to other therapies. To knowledge, it is the first evaluation of its kind.Methods and materials:Secondary research was conducted via EMBASE, MEDLINE, PubMed and Cochrane Library databases to explore a preferred blood preparation and combination treatment using MN.Results and discussion:Secondary research shows that there is more in-depth evidence that suggests platelet-rich plasma (PRP) is the preferred blood preparation for treating male AGA at present. However, studies show that iPRF has greater regenerative potential. More research currently exists to suggest that MN in combination with minoxidil (MX) therapy is preferred over iPRF combined with MN alone. No validated patient-reported outcome measures (PROMs) currently exist for male AGA, although PROMs do exist for facial aesthetic treatments and alopecia areata.Conclusions:Studies show that iPRF combined with MN is a safe and effective option for the treatment of male AGA, but comparison studies against other combinations are lacking. Other monotherapy and combination methods are generally more evidenced. The secondary research also found that no specific PROM tool for measuring male AGA exists. Unless a specific PROM is developed and validated for male AGA, challenges around treatment comparison will continue to limit evidence. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Aesthetic Nursing Mark Allen Group

Combination therapy with injectable platelet-rich fibrin and microneedling for male androgenetic alopecia: an evaluation of current practice

Journal of Aesthetic Nursing , Volume 10 (9): 8 – Nov 2, 2021

Loading next page...
 
/lp/mark-allen-group/combination-therapy-with-injectable-platelet-rich-fibrin-and-Loz1lZeB9F
Publisher
Mark Allen Group
Copyright
Copyright © 2021 MA Healthcare Limited
ISSN
2050-3717
eISSN
2052-2878
DOI
10.12968/joan.2021.10.9.408
Publisher site
See Article on Publisher Site

Abstract

Introduction:Within the past 20 years, significant advances have taken place within the realm of aesthetic medicine to manage hair loss. Several human blood preparations have been found to contain regenerative properties suitable for hair rejuvenation and, subsequently, have emerged onto the market. An advanced and liquid version of platelet-rich fibrin, injectable platelet-rich fibrin (iPRF) is one such product. This article evaluates the combination of iPRF with microneedling (MN) for the treatment of male androgenetic alopecia (AGA) compared to other therapies. To knowledge, it is the first evaluation of its kind.Methods and materials:Secondary research was conducted via EMBASE, MEDLINE, PubMed and Cochrane Library databases to explore a preferred blood preparation and combination treatment using MN.Results and discussion:Secondary research shows that there is more in-depth evidence that suggests platelet-rich plasma (PRP) is the preferred blood preparation for treating male AGA at present. However, studies show that iPRF has greater regenerative potential. More research currently exists to suggest that MN in combination with minoxidil (MX) therapy is preferred over iPRF combined with MN alone. No validated patient-reported outcome measures (PROMs) currently exist for male AGA, although PROMs do exist for facial aesthetic treatments and alopecia areata.Conclusions:Studies show that iPRF combined with MN is a safe and effective option for the treatment of male AGA, but comparison studies against other combinations are lacking. Other monotherapy and combination methods are generally more evidenced. The secondary research also found that no specific PROM tool for measuring male AGA exists. Unless a specific PROM is developed and validated for male AGA, challenges around treatment comparison will continue to limit evidence.

Journal

Journal of Aesthetic NursingMark Allen Group

Published: Nov 2, 2021

There are no references for this article.